Literature DB >> 1524114

Pathogenetic mechanisms in anterior proliferative vitreoretinopathy.

P F Lopez1, H E Grossniklaus, T M Aaberg, P Sternberg, A Capone, H M Lambert.   

Abstract

A clinicopathologic study of ten consecutive patients (ten eyes) undergoing surgery for rhegmatogenous retinal detachment with anterior proliferative vitreoretinopathy and a subsequent histopathologic, immunohistochemical, and ultrastructural study of ten enucleated eyes with anterior proliferative vitreoretinopathy were performed in order to elucidate relevant pathogenetic mechanisms. Our findings suggest that the pathogenetic evolution of anterior proliferative vitreoretinopathy occurs in three consecutive stages: (1) traction on the ciliary body and peripheral retina induced by fibrocellular contraction of the vitreous base; (2) incorporation of tractionally denuded components of the ciliary body and peripheral retina into the fibrocellular membranes overlying the vitreous base; and (3) proliferation of the incorporated components and fibrovascular ingrowth from the uvea, the retina, or both, into the fibrocellular membranes. Tractional disruption of the epithelium of the ciliary body pars plicata and breakdown of the ciliary blood-aqueous barrier are the principal pathogenetic mechanisms of chronic intractable hypotony and the post-vitrectomy fibrin syndrome in anterior proliferative vitreoretinopathy.

Entities:  

Mesh:

Year:  1992        PMID: 1524114     DOI: 10.1016/s0002-9394(14)71790-8

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  4 in total

Review 1.  Resveratrol and the eye: activity and molecular mechanisms.

Authors:  Christina Bola; Hannah Bartlett; Frank Eperjesi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-03-21       Impact factor: 3.117

2.  Intraretinal and periretinal pathology in anterior proliferative vitreoretinopathy.

Authors:  David G Charteris; John Downie; G William Aylward; Charanjit Sethi; Philip Luthert
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-04-13       Impact factor: 3.117

3.  AS-OCT of cyclitic membrane pre and post treatment with rtPA in the anterior chamber.

Authors:  Emma Marín Payá; Marina Aguilar González; Miriam Rahhal Ortuño; Paula Martínez López Corell; Jorge Vila Arteaga; Manuel Díaz Llopis
Journal:  Rom J Ophthalmol       Date:  2022 Apr-Jun

4.  Onset and recurrence of proliferative vitreoretinopathy in various vitreoretinal disease.

Authors:  H Mietz; K Heimann
Journal:  Br J Ophthalmol       Date:  1995-10       Impact factor: 4.638

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.